Point72 Hong Kong LTD Sutro Biopharma, Inc. Transaction History

Point72 Hong Kong LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$3.41 - $8.95 $30,120 - $79,055	8,833 New	8,833 $46,000
Q4 2021 Feb 14, 2022	SELL	$14.25 - $23.53 $18,938 - $31,271	-1,329 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$16.88 - $22.38 $11,174 - $14,815	662 Added 99.25%	1,329 $25,000
Q2 2021 Aug 16, 2021	SELL	$18.03 - $23.82 $2,920 - $3,858	-162 Reduced 19.54%	667 $12,000
Q1 2021 May 17, 2021	BUY	$20.29 - $27.54 $16,820 - $22,830	829 New	829 $19,000
Q3 2020 Nov 16, 2020	SELL	$7.44 - $13.15 $5,490 - $9,704	-738 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.24 - $11.05 $5,343 - $8,154	738 New	738 $6,000

137

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $136M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.